Vaccines

Catalent to Manufacture Drug Substance for AstraZeneca’s COVID-19 Vaccine Candidate

August 24, 2020

Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.

Novavax’s COVID-19 Vaccine Candidate Enters into Phase II Clinical Trials

August 24, 2020

The Phase II trial is a randomized, placebo-controlled, observer-blinded study that will include patients aged 18 to 84 years.

EC Reaches Agreement with AstraZeneca on Purchase of COVID-19 Vaccine

August 20, 2020

EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.

Novavax Signs Term Sheet with UK Gov for COVID-19 Vaccine Doses

August 20, 2020

Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial.

Expanding Options for Vaccine Packaging

August 19, 2020

Plastic primary packaging could help prevent supply chain shortages associated with high demand for COVID-19 vaccines.

Novavax Collaborates with SK bioscience for COVID-19 Vaccine Candidate

August 13, 2020

SK bioscience will manufacture the vaccine antigen component for use in the final drug product at its vaccine facility in Andong L-house, South Korea.

US Government Awards Moderna $1.5 billion for COVID-19 Vaccine Candidate

August 13, 2020

In combination with BARDA’s previous award, the commitment for early access to Moderna’s vaccine candidate has now reached to up to $2.48 billion.

Takeda and Novavax Team Up for COVID-19 Vaccine Development in Japan

August 11, 2020

The companies will collaborate on the manufacturing, clinical development, and regulatory activities for Novavax’s COVID-19 vaccine in Japan.

Grand River Selected for Operation Warp Speed Efforts

August 11, 2020

The CDMO will offer capacity for manufacturing and distributing COVID-19 vaccines and therapeutics at its Grand Rapids, MI, fill/finish facility.

Sanofi and GSK to Supply COVID-19 Vaccine to US Government and European Union

August 07, 2020

Sanofi and GlaxoSmithKline have been selected to supply the US government and the European Union with millions of doses of their COVID-19 vaccine candidate.